Frazier Life Sciences Management L.P. cut its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 0.2% during the fourth quarter, Holdings Channel reports. The fund owned 1,026,420 shares of the company’s stock after selling 1,593 shares during the period. Frazier Life Sciences Management L.P.’s holdings in Tyra Biosciences were worth $14,216,000 […]
Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]
Frazier Life Sciences Management L.P. lifted its holdings in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) by 4.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,131,008 shares of the biotechnology company’s stock after buying an additional 145,251 shares during the quarter. Alpine […]
Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]
Frazier Life Sciences Management L.P. bought a new position in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,184,840 shares of the company’s stock, valued at approximately $15,758,000. Frazier Life Sciences Management L.P. owned 1.93% of Dyne Therapeutics at […]